L3Harris Nears $500M Deal to Sell Majority Stake in Space Propulsion Portfolio to AE Industrial 
Saks Global Enterprises Seeks $1 Billion Loan Amid Possible Chapter 11 Bankruptcy Filing 
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Samsung to Double AI-Powered Mobile Devices with Google Gemini in Global AI Race 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Tesla Poised for Breakout Year in 2026 as New Products and EV Market Reset Drive Growth 
Kia Targets 3.35 Million Global Vehicle Sales in 2026 Amid Steady Growth Outlook 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
SMIC Shares Climb as China Boosts Chipmaking Support Amid AI Optimism 
NEW YORK, March 31, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Platform Specialty Products Corporation (“Platform”) (NYSE:PAH) between February 17, 2015 and March 14, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Florida. If you purchased or otherwise acquired Platform securities between February 17, 2015 and March 14, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/platform-specialty-products-corporation.
On February 17, 2015, Platform completed its acquisition of Arysta LifeScience Limited. The complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Arysta made improper third-party payments in West Africa; (2) such payments were unlawful under the U.S. Foreign Corrupt Practices Act; and (3) as a result, Platforms’ public statements were materially false and misleading at all relevant times.
If you suffered a loss in Platform you have until June 1, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/platform-specialty-products-corporation.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
